ARCs Receiving Funding for 2024/2025

The Evans Center IBR is pleased to announce the Affinity Research Collaboratives (ARCs) that have been awarded funding for the 2024/2025 year:

ARCs (as of 2024):

(Yr1) Innovative Technology and Novel Biomarker Discovery and Development for Disease Diagnosis and Treatment (B4D-ARC) (2024-present) / Co-Directors: Drs. Weining Lu, Manju Subramanian, Joel Henderson, Liangliang Hao

(Yr2) Tuberculosis Interdisciplinary Approach to Research (2023-present) Co-Directors: Drs. Karen Jacobson, Charles ‘Bob’ Horsburgh, Laura White

(Yr2) Musculoskeletal Biology Over a Lifespan (CeMH) (2023-present) Co-Directors: Drs. Paola Divieti Pajevic, David Felson and LaDora Thompson

BIT-ARC, Year 1 (as of Nov 2024)

Developing an artificial intelligence digital pathology diagnostic tool for proteinuric kidney disease / Co-Directors: Drs. Weining Lu* (primary contact), Chao Zhang, Joel Henderson, William Tomlinson, and Vijaya Kolachalama

Continuing ARCs and ARC Programs:

A Multi-Disciplinary Program to Identify Predictors of Efficacy and Resistance to Cancer Checkpoint Inhibition (PIPER-C ARC) Co-Directors: Drs. Matthew Kulke, Evan Johnson, David Sherr and Gerald Denis

Respiratory Viruses: a focus on COVID-19 Program / Director: Dr. Markus Bosmann; Co-Director: Dr. Mohsan Saeed

Thrombosis and Hemostasis ARC Program Co-Directors: Drs. Vipul Chitalia, Katya Ravid, Jean Francis

Precision Medicine for Alzheimer Disease and Related Disorders ARC Program / Co-Directors: Drs. Lindsay Farrer, Rhoda Au and Alice Cronin-Golomb

Mobile and Electronic (ME)-HealthARC Program /Director: Dr. Belinda Borrelli; Leadership: Drs. Rebecca Mishuris and Swathi Kiran

Fibrosis ARC: Connecting Tissues and Investigators (FCTI)ARC Program / Co-Directors: Drs. Maria Trojanowska, Irving Bigio and Xaralabos ‘Bob’ Varelas